DNA Damage Response (DDR) and PARP inhibitors are promising but complex therapeutic strategies not yet widely known by healthcare professionals working in oncology. This accredited e-learning covers the role of PARP inhibitors in clinical practice, at present and in the near future.


Upon completion of this e-learning you will understand why, where and how PARP inhibitors work in clinical practice, providing you with tools you can apply in your daily practice. It is designed to support you in selecting the appropriate treatment strategy with PARP inhibitors in the appropriate patient population and to provide the best possible care.